| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $565M | — | $501M | — | 12.7% |
| Op. Income | $178M | — | $144M | — | 23.4% |
| Gross Margin | 69.2% | — | 66.9% | — | 2.2pp |
| Net Margin | 24.8% | — | 22.9% | — | 2.0pp |
| EPS (Diluted) | $4.75 | — | $3.89 | — | 22.1% |
| Free Cash Flow | $154M | — | $133M | — | 15.8% |
| Item | Amount |
|---|---|
| REVENUE | $565M |
| Cost of Revenue | $174M |
| GROSS PROFIT | $391M |
| R&D Expenses | $0 |
| Selling & Marketing | $8M |
| General & Administrative | $111M |
| SG&A Expenses | $118M |
| Other Expenses | $94M |
| Operating Expenses | $212M |
| Cost & Expenses | $386M |
| OPERATING INCOME | $178M |
| Interest Income | $468M |
| Interest Expense | $167M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $178M |
| Income Tax Expense | $38M |
| Net Income from Continuing Ops | $140M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $140M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $140M |
| D&A | $0 |
| EBIT | $178M |
| EBITDA | $178M |
| EPS | $5 |
| EPS Diluted | $5 |
| Item | Amount |
|---|---|
| REVENUE | $565M |
| Cost of Revenue | $174M |
| GROSS PROFIT | $391M |
| R&D Expenses | $0 |
| Selling & Marketing | $8M |
| General & Administrative | $111M |
| SG&A Expenses | $118M |
| Other Expenses | $94M |
| Operating Expenses | $212M |
| Cost & Expenses | $386M |
| OPERATING INCOME | $178M |
| Interest Income | $468M |
| Interest Expense | $167M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $178M |
| Income Tax Expense | $38M |
| Net Income from Continuing Ops | $140M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $140M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $140M |
| D&A | $0 |
| EBIT | $178M |
| EBITDA | $178M |
| EPS | $5 |
| EPS Diluted | $5 |
| Item | Amount |
|---|---|
| Net Income | $140M |
| Depreciation & Amortization | $8M |
| Stock-Based Compensation | $4M |
| Deferred Income Tax | -$3M |
| Other Non-Cash Items | $3M |
| Change in Working Capital | $13M |
| OPERATING CASH FLOW | $166M |
| Capital Expenditure | -$12M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$595M |
| Sales/Maturities of Investments | $1.1B |
| Other Investing Activities | -$584M |
| NET CASH FROM INVESTING | -$107M |
| Net Debt Issuance | -$50M |
| Common Stock Repurchased | -$2M |
| Common Dividends Paid | -$37M |
| Other Financing Activities | $625M |
| NET CASH FROM FINANCING | $536M |
| FREE CASH FLOW | $154M |
| Net Change in Cash | $595M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $70M |
| Short-Term Investments | $816M |
| Net Receivables | $29M |
| Inventory | $0 |
| Other Current Assets | -$38M |
| TOTAL CURRENT ASSETS | $886M |
| PP&E (Net) | $0 |
| Goodwill | $194M |
| Intangible Assets | $12M |
| Long-Term Investments | $8.1B |
| Tax Assets | $0 |
| Other Non-Current Assets | $362M |
| TOTAL NON-CURRENT ASSETS | $8.6B |
| TOTAL ASSETS | $9.5B |
| Account Payables | $2M |
| Short-Term Debt | $124M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $7.8B |
| TOTAL CURRENT LIABILITIES | $7.9B |
| Long-Term Debt | $327M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $20M |
| Other Non-Current Liabilities | $8.0B |
| TOTAL NON-CURRENT LIABILITIES | $8.4B |
| TOTAL LIABILITIES | $8.5B |
| Common Stock | $59M |
| Additional Paid-In Capital | $403M |
| Retained Earnings | $675M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$61M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.1B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.1B |
| TOTAL LIABILITIES & EQUITY | $9.5B |
| Total Debt | $480M |
| Net Debt | $409M |
